Staar Surgical Co. (STAA) Shares Up Despite Recent Market Volatility

The stock price of Staar Surgical Co. (NASDAQ: STAA) has surged by 15.25 when compared to previous closing price of 39.07, but the company has seen a 19.44% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-02-27 that The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Is It Worth Investing in Staar Surgical Co. (NASDAQ: STAA) Right Now?

Staar Surgical Co. (NASDAQ: STAA) has a price-to-earnings ratio that is above its average at 104.16x. The stock has a 36-month beta value of 0.87. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for STAA is 48.34M, and at present, short sellers hold a 11.24% of that float. On April 04, 2024, the average trading volume of STAA was 723.45K shares.

STAA’s Market Performance

STAA stock saw an increase of 19.44% in the past week, with a monthly gain of 35.31% and a quarterly increase of 54.21%. The volatility ratio for the week is 4.60%, and the volatility levels for the last 30 days are 4.92% for Staar Surgical Co. (STAA). The simple moving average for the last 20 days is 19.11% for STAA stock, with a simple moving average of 15.03% for the last 200 days.

Analysts’ Opinion of STAA

Many brokerage firms have already submitted their reports for STAA stocks, with Stifel repeating the rating for STAA by listing it as a “Buy.” The predicted price for STAA in the upcoming period, according to Stifel is $50 based on the research report published on March 11, 2024 of the current year 2024.

Morgan Stanley gave a rating of “Equal-Weight” to STAA, setting the target price at $35 in the report published on December 04th of the previous year.

STAA Trading at 34.61% from the 50-Day Moving Average

After a stumble in the market that brought STAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.42% of loss for the given period.

Volatility was left at 4.92%, however, over the last 30 days, the volatility rate increased by 4.60%, as shares surge +23.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +44.25% upper at present.

During the last 5 trading sessions, STAA rose by +16.74%, which changed the moving average for the period of 200-days by -16.35% in comparison to the 20-day moving average, which settled at $38.23. In addition, Staar Surgical Co. saw 44.28% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at STAA starting from WEISNER AIMEE S, who purchase 1,750 shares at the price of $38.11 back on Mar 14 ’24. After this action, WEISNER AIMEE S now owns 10,864 shares of Staar Surgical Co., valued at $66,692 using the latest closing price.

BROADWOOD PARTNERS, L.P., the 10% Owner of Staar Surgical Co., purchase 4,042 shares at $27.11 during a trade that took place back on Jan 08 ’24, which means that BROADWOOD PARTNERS, L.P. is holding 10,768,430 shares at $109,570 based on the most recent closing price.

Stock Fundamentals for STAA

Current profitability levels for the company are sitting at:

  • 0.09 for the present operating margin
  • 0.78 for the gross margin

The net margin for Staar Surgical Co. stands at 0.07. The total capital return value is set at 0.07. Equity return is now at value 5.95, with 4.72 for asset returns.

Based on Staar Surgical Co. (STAA), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 0.41.

Currently, EBITDA for the company is 33.22 million with net debt to EBITDA at -4.02. When we switch over and look at the enterprise to sales, we see a ratio of 6.39. The receivables turnover for the company is 3.29for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.62.


To sum up, Staar Surgical Co. (STAA) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts